Nucleogene has been founded in 2019, as a new strategic business unit, production and marketing experience of the last 10 years. Nucleogene develops products using biotechnology methods for medical and industrial use and aims to meet the “healthier life” demands of individuals and to supply products and high safety diagnosis methods for the health and food industries.
Nucleogene is also determined to allocate its resources in the most efficient way to develop the products and technology which will meet the future demands of health and food industries.